Currently approved therapies for COVID‐19 are mostly limited by their low availability, high
costs or the requirement of parenteral administration by trained medical personnel in an in …

Background The reactivation of herpesviruses (HHV) in COVID-19 patients is evident in the
literature. Several reports have been published regarding the reactivation of these viruses …

The coronavirus disease 2019 (COVID-19) pandemic has caused significant medical, social,
and economic impacts globally, both in the short and long term. Although most individuals …

Background Although numerous modalities are currently in use for the treatment and
prophylaxis of COVID-19, probiotics are a cost-effective alternative that could be used in …

Background Understanding the association between sleep quality and COVID-19 outcomes
is crucial for effective preventive strategies and patient management. This systematic review …

Antiandrogens may carry a potential benefit as a therapeutic agent against COVID‐19.
However, studies have been yielding mixed results, thus hindering any objective …

Information Classification: General impact on the morbidity and mortality of patients
worldwide. In an effort to address this ongoing public health crisis, researchers and …

Immunostaining in lungs of patients who died with COVID-19 infection showed increased
intensity and distribution of chondroitin sulfate and decline in N-acetylgalactostamine-4 …

Background A comprehensive guideline named “Diagnostic Therapeutic Flow Chart for
Covid-19 ″(DTFC) was released by the Scientific Committee of Covid-19 of Iran's Ministry of …

Introduction Severe acute respiratory syndrome coronavirus 2 is a viral respiratory infection
that can cause systemic disorders and lead to death, particularly in older people. Proton …